Latest Breaking News On - Antibody in development - Page 1 : comparemela.com

Arix Bioscience PLC: Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102

Arix Bioscience PLC: Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-kingdom
United-states
London
City-of
Ciara-kennedy
Robert-lyne
Arix-bioscience
Nick-johnson
Ibrahim-khalil
News-service
Antibody-in-development
Sorriso-pharmaceuticals-press

Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102

Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

London
City-of
United-kingdom
United-states
Ciara-kennedy
Ibrahim-khalil
Arix-bioscience
Nick-johnson
Robert-lyne
Sarah-macleod
Company-phase
Sorriso-pharmaceuticals

Gilead to Acquire All Remaining Rights to Potential First-in-Class Immunotherapy GS-1811 From Jounce Therapeutics

Gilead to Acquire All Remaining Rights to Potential First-in-Class Immunotherapy GS-1811 From Jounce Therapeutics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

California
United-states
Cambridge
Cambridgeshire
United-kingdom
Foster-city
Meaghan-smith
Jacquie-ross
Eric-laub
Richard-murray
Exchange-commission
Gilead-sciences